The approval of a new drug to treat Alzheimer’s disease is controversial. The U.S. Food and Drug Administration gave full approval to the drug lecanemab (Leqembi) Thursday to treat adults with Alzheimer’s disease. In January, Public Citizen, a consumer advocacy organization, urged the agency not to approve the drug. In a letter to the FDA, it said that lecanemab investigators have concluded that longer trials are needed to determine the effectiveness and safety of lecanemab in early Alzheimer’s disease, and that three deaths thought to be related to the drug have now occurred in lecanemab... Continue Reading
Posts Tagged With ‘ Prescription Drugs ’
Full approval of lecanemab to treat Alzheimer’s by the FDA fails patients and the public, consumer group says
July 11th, 2023
What’s antibiotic resistance and what you can do about it
January 27th, 2023
I’ve written about antibiotic resistance a number of times, and I have a section on it in the draft book on my journalism work. What is antibiotic resistance? Antibiotic resistance happens when germs such as bacteria and fungi develop the ability to defeat the drugs designed to kill them. That means the germs aren’t killed and continue to grow. Resistant infections can be difficult, and sometimes impossible, to treat. The misuse of medically important antibiotics is contributing to the rise and spread of antibiotic-resistant bacteria. It’s a growing public health crisis that’s responsible... Continue Reading